 options available for the treatment of acute
iliofemoral DVT, it is unlikely that all patients would
choose a strategy of surgical thrombectomy, catheterdirected pharmacologic thrombolysis, or pharmacomechanical thrombolysis. Individual patients undoubtedly place
different values on the benefits of avoiding the postthrombotic syndrome vs the risks and burdens of a surgical
procedure or bleeding. Most patients place a higher value
on avoiding early death than on avoiding late outcomes
